Inhaled glucagon: A new hope for severe hypoglycemia in type 1 diabetes
Until now injectable glucagon was the only available treatment used in the management of severe hypoglycemia wherein glucagon had to be prepared in several steps before administration. This method of delivery of injectable glucagon being cumbersome and unappealing for a wide majority of the patients...
Main Authors: | Salva Fatima Heba, Uzma Parveen, Sara Sana Ayesha Khanum, Maaria Gulnaaz, Maimuna Tabassum, Syeda Batool Safiyya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Diabetology |
Subjects: | |
Online Access: | http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2021;volume=12;issue=2;spage=114;epage=119;aulast=Heba |
Similar Items
-
Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons
by: Antonio E. Pontiroli, et al.
Published: (2022-12-01) -
Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?
by: Francesca Porcellati, et al.
Published: (2021-08-01) -
Neuronal regulation of glucagon secretion and gluconeogenesis
by: Bernard Thorens
Published: (2022-04-01) -
New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions
by: Lucia La Sala, et al.
Published: (2021-09-01) -
An Evaluation of Glucagon Injection Anxiety and Its Association with the Fear of Hypoglycemia among the Parents of Children with Type 1 Diabetes
by: Serra Muradoğlu, et al.
Published: (2021-09-01)